Globus Medical, Inc.

NYSE:GMED

Medical - Devices

Healthcare
$70.53 -2.71%

-$2.10 today

Market cap
$9.34B
Beta
0.95
P/E (TTM)
17.4
EPS (TTM)
$4.33
52W Low $51.79High $101.40

Volume 1.43M

Average 1.45M

GMED Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Globus Medical, Inc.NYSE: GMED

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 69.4%

Gross margin was 69.4% in Q2 FY2026, up 2.8 pp from a year earlier. On a trailing-twelve-month basis it was 68.5%, up 5.8 pp year over year. Over 3 fiscal years it narrowed by 6.8 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
69.4%+0.2 pp QoQ
Last fiscal yearDec 2025
67.4%+8.5 pp YoY
LTMJun 2026
68.5%+5.8 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.8 pp——
1 year+8.5 pp——
3 years-6.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
67.4%
Year-over-year change
+8.5pp

Gross Margin vs competitors

How GMED compares with its peers on the latest reported figures

  • GMED's LTM Jun 2026 gross margin of 68.5% is the 5th highest of the 10 companies compared; the peer median is 68.3%.
  • Its year-over-year change of +5.8 pp is the highest of 10, against a peer median of +0.3 pp.
  • Over three fiscal years its change of -6.8 pp compares with a peer median of -1.1 pp.
GMED Competitors Peer median
Gross Margin for GMED and competitors
Company Period LTM level YoY 3-year change
SIBNSI-BONE, Inc.LTM Mar 202679.6% +0.3 pp-5.7 pp
KIDSOrthoPediatrics Corp.LTM Mar 202673.1% +0.3 pp-1.1 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202669.9% -1.2 pp-9.3 pp
OFIXOrthofix Medical Inc.LTM Mar 202669.0% +1.9 pp-6.1 pp
GMEDGlobus Medical, Inc.LTM Jun 202668.5% +5.8 pp-6.8 pp
SNNSmith & Nephew plcFY202568.3% -2.0 pp-2.7 pp
BVSBioventus Inc.LTM Mar 202667.8% +0.6 pp+2.7 pp
ATECAlphatec Holdings, Inc.LTM Mar 202665.3% -3.6 pp+3.2 pp
SYKStryker CorporationLTM Jun 202665.2% +2.3 pp+4.1 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 202662.3% +4.2 pp+7.5 pp
Peer median (excluding GMED) 68.3%+0.3 pp-1.1 pp

Competitors are the stored peer set for GMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue958.1M1.02B1.57B2.52B2.94B
Cost of Revenue239.22M263.73M548.17M1.04B957.8M
Gross Profit718.88M759.12M1.02B1.48B1.98B
Gross Margin75.0%74.2%65.1%58.9%67.4%
Research & Development97.35M73.02M124.01M163.75M185M
Selling, General & Admin408.15M432.12M643.41M981.05M1.32B
Operating Expenses546.93M531.17M887.16M1.32B1.5B
Depreciation & Amortization69.87M68.25M144.73M254.02M276.84M
EBITDA264.73M304.5M346.58M473.73M886.74M
EBITDA Margin27.6%29.8%22.1%18.8%30.2%
Operating Income171.95M227.95M133.14M165.99M479.8M
Operating Margin17.9%22.3%8.5%6.6%16.3%
Interest Income9.3M14.23M20.13M07.14M
Interest Expense0004.19M0
Other Income / Expenses8.45M15.07M32.25M(45.27M)130.1M
Income Before Tax180.41M243.02M165.39M120.72M609.9M
Pre-Tax Margin18.8%23.8%10.5%4.8%20.8%
Income Tax Expense31.22M52.85M42.52M17.74M72M
Net Income149.19M190.17M122.87M102.98M537.9M
Net Margin15.6%18.6%7.8%4.1%18.3%
EPS (Basic)1.481.891.090.763.98
EPS (Diluted)1.441.851.070.753.92
Weighted Avg Shares100.73M100.47M113.09M135.73M135.15M
Weighted Avg Shares (Diluted)103.62M102.64M114.63M137.86M137.22M

Globus Medical, Inc.

NYSE:GMED

Intrinsic Alpha fair value

Locked

Current Price

$70.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.